Author

Adolfo G Mauro

Unknown affiliation - Cited by 2,327

Biography

Adolfo Gabriele Mauro currently works at the Molecular Medicine Research Building, Virginia Commonwealth University. Adolfo does research in Internal Medicine (General Medicine), Cardiothoracic Surgery and Cardiology. Their most recent publication is 'Inhibiting the inflammatory injury following myocardial ischemia reperfusion with plasma derived α-1 anti-trypsin: a post-hoc analysis of the VCU-α1RT study'.
Title
Cited by
Year
Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review
JG Chiabrando, A Bonaventura, A Vecchié, GF Wohlford, AG Mauro, ...Journal of the American College of Cardiology 75 (1), 76-92, 2020202
226
2020
Inflammasome formation in the lungs of patients with fatal COVID-19
S Toldo, R Bussani, V Nuzzi, A Bonaventura, AG Mauro, A Cannatà, ...Inflammation Research 70, 7-10, 2021202
105
2021
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion
IW Tengesdal, DR Menon, DG Osborne, CP Neff, NE Powers, F Gamboni, ...Proceedings of the National Academy of Sciences 118 (10), e2000915118, 2021202
78
2021
NLRP3 inflammasome in acute myocardial infarction
AG Mauro, A Bonaventura, E Mezzaroma, M Quader, S ToldoJournal of Cardiovascular Pharmacology 74 (3), 175-187, 2019201
73
2019
Low density lipoprotein receptor-related protein-1 in cardiac inflammation and infarct healing
N Potere, MG Del Buono, AG Mauro, A Abbate, S ToldoFrontiers in cardiovascular medicine 6, 51, 2019201
52
2019
The role of NLRP3 inflammasome in pericarditis: potential for therapeutic approaches
AG Mauro, A Bonaventura, A Vecchié, E Mezzaroma, S Carbone, ...Basic to Translational Science 6 (2), 137-150, 2021202
33
2021
Clinical presentation and outcomes of acute pericarditis in a large urban hospital in the United States of America
A Vecchié, JG Chiabrando, MS Dell, A Bonaventura, AG Mauro, ...Chest 158 (6), 56-67, 2020202
25
2020
Remote ischemic pre-conditioning attenuates adverse cardiac remodeling and mortality following doxorubicin administration in mice
ZM Gertz, C Cain, D Kraskauskas, T Devarakonda, AG Mauro, ...Cardio Oncology 1 (2), 2-234, 2019201
21
2019
Preservation of Contractile Reserve and Diastolic Function by Inhibiting the NLRP3 Inflammasome with OLT1177® (Dapansutrile) in a Mouse Model of Severe …
J Aliaga, A Bonaventura, E Mezzaroma, Y Dhakal, AG Mauro, A Abbate, ...Molecules 26 (12), 3534, 2021202
18
2021
Inflammasome formation in granulomas in cardiac sarcoidosis
J Kron, AG Mauro, A Bonaventura, S Toldo, FN Salloum, KA Ellenbogen, ...Circulation: Arrhythmia and Electrophysiology 12 (9), e007582, 2019201
16
2019
An update on the pathophysiology of acute and recurrent pericarditis.
A Bonaventura, A Vecchié, AG Mauro, AL Brucato, M Imazio, A AbbatePanminerva Medica 63 (3), 249-260, 2020202
15
2020
Determinants of cardiorespiratory fitness following thoracic radiotherapy in lung or breast cancer survivors
JM Canada, CR Trankle, S Carbone, LF Buckley, M de Chazal, ...The American journal of cardiology 125 (6), 988-996, 2020202
14
2020
B7‐33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction–Related Adverse Cardiac Remodeling in Mice
T Devarakonda, AG Mauro, G Guzman, S Hovsepian, C Cain, A Das, ...Journal of the American Heart Association 9 (8), e015748, 2020202
12
2020
Hydrogen sulfide therapy suppresses cofilin-2 and attenuates ischemic heart failure in a mouse model of myocardial infarction
K Nguyen, VQ Chau, AG Mauro, D Durrant, S Toldo, A Abbate, A Das, ...Journal of cardiovascular pharmacology and therapeutics 25 (5), 472-483, 2020202
11
2020
Cardiac gene therapy with relaxin receptor 1 overexpression protects against acute myocardial infarction
T Devarakonda, AG Mauro, C Cain, A Das, FN SalloumBasic to Translational Science (1), 53-63, 2022202
7
2022
Drugs to inhibit the NLRP3 inflammasome: not always on target
AG Mauro, A Bonaventura, A AbbateJournal of Cardiovascular Pharmacology 74 (3), 225-227, 2019201
6
2019
Advances in pharmacotherapy for acute and recurrent pericarditis
A Vecchié, MG Del Buono, AG Mauro, PC Cremer, M Imazio, AL Klein, ...Expert Opinion on Pharmacotherapy 23 (), 81-91, 2022202
6
2022
Refining murine heterotopic heart transplantation: A model to study ischemia and reperfusion injury in donation after circulatory death hearts
M Quader, R Cholyway, N Wickramaratne, O Akande, M Mangino, ...Animal Models and Experimental Medicine (3), 283-296, 2021202
4
2021
Chronic treatment with serelaxin mitigates adverse remodeling in a murine model of ischemic heart failure and modulates bioactive sphingolipid signaling
T Devarakonda, J Valle Raleigh, AG Mauro, JM Lambert, LA Cowart, ...Scientific Reports 12 (1), 8897, 2022202
4
2022
The interleukin-1 receptor type I promotes the development of aging-associated cardiomyopathy in mice
P Narayan, E Trikantzopoulos, E Mezzaroma, AG Mauro, H Vohra, ...Cytokine 151, 155811, 2022202
3
2022

Referred From: https://scholar.google.com/citations?user=LnCDeI8AAAAJ&hl=en

Cited by
Citations 2327
h-index 24
i10-index 37
Recommended Journals
Open Access Journals